Aadc Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AADC is the enzyme that converts L-DOPA to dopamine. [1]
| Property | Value |
|---|---|
| Category | Neuromodulatory |
| Location | CNS, peripheral |
| Enzyme | Aromatic L-amino acid decarboxylase |
| Function | Catecholamine synthesis |
AADC neurons operate through several key molecular mechanisms:
| Gene/Protein | Function | Disease Relevance |
|---|---|---|
| AADC (DDC) | Dopamine synthesis enzyme | PD biomarker, gene therapy target |
| TH | Rate-limiting step | PD therapeutic target |
| VMAT2 | Neurotransmitter packaging | PD risk locus |
| DAT | Dopamine reuptake | PET imaging target |
| COMT | Dopamine metabolism | PD treatment target |
| BDNF | Neuronal survival | Neuroprotective therapy |
| LRRK2 | Kinase dysfunction | Genetic PD risk |
The study of Aadc Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kuhl DE. AADC imaging in PD. Annals of Neurology. 2020. ↩︎